Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Guazuma ulmifolia*, commonly known as mutamba or West Indian Elm, is a medicinal plant native to the tropical regions of the Americas. It is extensively utilized in traditional medicine for its diverse therapeutic properties, including use as a slimming agent, an antidiabetic, and a treatment for gastrointestinal and respiratory disorders. The plant extracts, derived from leaves, bark, and fruit, are rich in bioactive phytochemicals such as flavonoids (including proanthocyanidins and catechins), tannins, and phenolic acids. Clinical and preclinical research has focused on its potential to improve metabolic profiles in Type 2 Diabetes Mellitus, inhibit HMG-CoA reductase for antihyperlipidemic effects, and provide hepatoprotection against oxidative stress. Additionally, it has demonstrated anthelmintic activity against parasites like *Haemonchus contortus* and antiplasmodial activity against malaria. Beyond medicine, it is explored as a natural coagulant for water treatment and a nutritional supplement for livestock.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on guazuma ulmifolia.